DoH Policies screened during the period: 1 January 2021 - 31 March 2021

In fulfilling its obligations under Section 75 the Department is required to equality screen all of its policies and services under consideration to determine whether they should be subject to a full equality impact.

Documents

Screening Template - The COVID-19 vaccination programme
PDF (416 KB)

NICE Technology Appraisal TA663 - Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia
PDF (341 KB)

NICE Technology Appraisal TA664 - Liraglutide for managing overweight and obesity
PDF (343 KB)

NICE Technology Appraisal TA665 - Upadacitinib for treating severe rheumatoid arthritis
PDF (345 KB)

NICE Technology Appraisal TA666 - Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma
PDF (341 KB)

NICE Technology Appraisal TA667 - Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura
PDF (329 KB)

NICE Technology Appraisal TA668 - Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer
PDF (327 KB)

NICE Public Health Guideline NG135 - Alcohol interventions in secondary and further education
PDF (328 KB)

NICE Technology Appraisal TA669 - Trifluridine–tipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more therapies
PDF (327 KB)

NICE Technology Appraisal TA670 - Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitor
PDF (327 KB)

NICE Technology Appraisal TA679 - Dapagliflozin for treating chronic heart failure with reduced ejection fraction
PDF (343 KB)

NICE Technology Appraisal TA677 - Autologous anti-CD19-transduced CD3+ cells for treating relapsed or refractory mantle cell lymphoma
PDF (438 KB)

NICE Technology Appraisal TA676 - Filgotinib for treating moderate to severe rheumatoid arthritis
PDF (341 KB)

NICE Technology Appraisal TA672 - Brolucizumab for treating wet age-related macular degeneration
PDF (341 KB)

NICE Technology Appraisal TA671 - Mepolizumab for treating severe eosinophilic asthma (review of TA431)
PDF (342 KB)

NICE Technology Appraisal TA673 - Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy
PDF (328 KB)

Online COVID – 19 Vaccination Booking Platform
PDF (752 KB)

Provision of Health Services to Persons Not Ordinarily Resident (Amendment) Regulations (Northern Ireland) 2021
PDF (550 KB)

The Health Protection (Coronavirus, Restrictions) Regulations (Northern Ireland) 2021
PDF (699 KB)

The Health Protection (Coronavirus, International Travel) Regulations (Northern Ireland) 2021
PDF (521 KB)

Autism Interim Strategy 2021-2022
PDF (721 KB)

Making of a Statutory Rule of the Public Health Act (Northern Ireland) 1967, whereby Schedule 1 to the Act (Notifiable Diseases) shall be amended by the insertion of Hepatitis C
PDF (515 KB)

Grant Scheme to support carers
PDF (544 KB)

Adoption and Children Bill 2020
PDF (887 KB)

Continuing healthcare in Northern Ireland
PDF (493 KB)

Policy proposals for the statutory Duty of Candour and Being Open Framework
PDF (564 KB)

Help viewing documents